The era of biologics and reparative medicine: a pivotal clinical trial of platelet-derived growth factor for periodontal regeneration.
Reynolds
Mark A
MA
Aichelmann-Reidy
Mary Elizabeth
ME
D016301:Alveolar Bone Loss / Q000601:surgery*; D000077214:Becaplermin; D001861:Bone Regeneration / Q000187:drug effects*; D004311:Double-Blind Method; D016557:Guided Tissue Regeneration, Periodontal; D006801:Humans; D017622:Periodontal Attachment Loss / Q000601:surgery*; D010514:Periodontal Pocket / Q000601:surgery; D010982:Platelet-Derived Growth Factor / Q000627:therapeutic use*; D011446:Prospective Studies; D020574:Proto-Oncogene Proteins c-sis; D016032:Randomized Controlled Trials as Topic; D011994:Recombinant Proteins; D012449:Safety; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects
D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; D011994:Recombinant Proteins; D000077214:Becaplermin